A Phase 1 Open Label Exploratory Study of an Autologous Neo-Urinary Conduit in Subjects Requiring Incontinent Urinary Diversion Following Radical Cystectomy
Phase of Trial: Phase I
Latest Information Update: 19 Mar 2019
Price : $35 *
At a glance
- Drugs Autologous cultured urological tissue cells (Primary)
- Indications Urination disorders
- Focus Adverse reactions; First in man; Therapeutic Use
- Sponsors Tengion
- 21 May 2018 Final results presented at the 113th Annual Meeting of the American Urological Association.
- 09 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.